SCHEDULE 13G/A: BlackRock Amends IDEXX Laboratories Stake, Reports 9.4% Passive Ownership
Beneficial Ownership Report
BlackRock, Inc. has filed an Amendment No. 15 to its Schedule 13G, disclosing a 9.4% beneficial ownership stake in IDEXX Laboratories Inc. as of March 31, 2025.
Summary
- BlackRock, Inc. filed an Amendment No. 15 to its Schedule 13G regarding its beneficial ownership in IDEXX LABORATORIES INC.
- As of March 31, 2025, BlackRock, Inc. beneficially owns an aggregate of 7,599,078 shares of IDEXX LABORATORIES INC Common Stock.
- This represents 9.4% of the total outstanding common stock.
- BlackRock holds sole voting power over 7,085,151 shares and sole dispositive power over 7,599,078 shares, with no shared voting or dispositive power.
- The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of IDEXX LABORATORIES INC.
- Various BlackRock subsidiaries and affiliates are involved in the beneficial ownership, with some individual entities owning 5% or more of the outstanding shares.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing disclosing a passive ownership stake, providing factual information without expressing positive or negative sentiment regarding the issuer's performance or outlook.
Future Outlook
NA
Management Comments
- "By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11."
Industry Context
NA
Stakeholder Impact
- Shareholders: Provides transparency on a significant institutional holder's passive stake in the company.
Key Dates
| Date | Description |
|---|---|
| 2023-04-30 | Previous Power of Attorney revoked by the new one. |
| 2025-01-21 | Date of the new Power of Attorney. |
| 2025-03-31 | Date of event which requires filing of this statement (reporting date for ownership). |
| 2025-04-17 | Date of filing and signature of the Schedule 13G Amendment No. 15. |
Keywords
BlackRock, IDEXX Laboratories Inc, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Passive Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.